EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improved Predictability of Diagnosis and Prognosis Using Serum‐ and Tissue‐Derived Extracellular Vesicles From Bulk mRNA Sequencing in Pancreatic Ductal Adenocarcinoma

Qian Zhu iD, Zhang Chen, Ming Tian, Xin Yan iD, Xiangdong Gongye, Zhicheng Liu, Anbang Zhao, Zhiyong Yang, Yufeng Yuan

Cancer Medicine · 2025

DOI: 10.1002/cam4.70538 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Qian Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Biomarkers, Tumor, MicroRNAs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Cancer research and translational platform project of Zhongnan Hospital of Wuhan University, Grant from the Key Research and Development Program of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early‐stage pancreatic ductal adenocarcinoma (PDAC) is frequently misdiagnosed, contributing to its high mortality rate. Exosomal microRNAs (miRNAs) have emerged as potential biomarkers for the early detection of PDAC.

Aims

This study aimed to evaluate the feasibility of using exosomal miRNAs from PDAC tissues and serum as biomarkers for early detection and prognosis. Materials & Methods Exosomes were isolated from healthy individuals and PDAC patients via tissue and serum samples, then identified by analyzing their particle size and protein content. PDAC‐specific exosomal miRNAs were identified using a microRNA array. A large cohort was subsequently recruited to validate these findings. The diagnostic capacity of the identified miRNAs was assessed using the Brier score and area under the curve (AUC). Verified miRNAs were also used to confirm intracellular mRNA change patterns.

Results

The combination of miR142‐3p, miR148a‐3p, and CA199 showed a higher AUC (0.747) compared to CA199 alone (0.716) in ROC curve analysis. Gene Ontology (GO) annotations revealed that the two‐miRNA panel was associated with multiple oncogenic pathways.

Discussion

142‐3p and miR148a‐3p were identified as specific to PDAC and, when combined with CA199, improved diagnostic accuracy. Their involvement in oncogenic pathways underscores their relevance as diagnostic and prognostic biomarkers.

Conclusion

MiR142‐3p and miR148a‐3p, alongside CA199, show promise as non‐invasive biomarkers for early detection and prognosis of PDAC, improving diagnostic accuracy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsBiomarkers, TumorMicroRNAsRNA, MessengerExtracellular VesiclesHumansPrognosisMaleFemaleMiddle AgedAgedExosomesGene Expression Regulation, NeoplasticROC CurveEarly Detection of Cancer

Stichwörter der Autor:innen

Exosomal miRNAPDACdiagnosisexosomeprognosis

Substanzen

Biomarkers, TumorMicroRNAsRNA, Messenger

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary & Pancreatic Diseases of Hubei Province, Wuhan, China.
  • TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.

ORCID-Profile: Qian Zhu, Xin Yan

Förderung

  • the National Natural Science Foundation of China
  • Cancer research and translational platform project of Zhongnan Hospital of Wuhan University
  • Grant from the Key Research and Development Program of Hubei Province
  • Research Fund of the Health Commission of Hubei Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhu, Q., Chen, Z., Tian, M., Yan, X., Gongye, X., Liu, Z., Zhao, A., Yang, Z., & Yuan, Y. (2025). Improved Predictability of Diagnosis and Prognosis Using Serum‐ and Tissue‐Derived Extracellular Vesicles From Bulk mRNA Sequencing in Pancreatic Ductal Adenocarcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.70538

Vancouver

Zhu Q, Chen Z, Tian M, Yan X, Gongye X, Liu Z, et al. Improved Predictability of Diagnosis and Prognosis Using Serum‐ and Tissue‐Derived Extracellular Vesicles From Bulk mRNA Sequencing in Pancreatic Ductal Adenocarcinoma. Cancer Medicine. 2025. doi:10.1002/cam4.70538

BibTeX
@article{Zhu2025,
  author = {Zhu, Qian and Chen, Zhang and Tian, Ming and Yan, Xin and Gongye, Xiangdong and Liu, Zhicheng and Zhao, Anbang and Yang, Zhiyong and Yuan, Yufeng},
  title = {Improved Predictability of Diagnosis and Prognosis Using Serum‐ and Tissue‐Derived Extracellular Vesicles From Bulk mRNA Sequencing in Pancreatic Ductal Adenocarcinoma},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70538}
}
Kostenlos starten →